SAB Biotherapeutics Inc. (SABS)

NASDAQ: SABS · IEX Real-Time Price · USD
1.94
0.04 (2.11%)
May 26, 2022 4:00 PM EDT - Market closed

Balance Sheet (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Cash & Equivalents
39.5512.616.35
Cash & Cash Equivalents
39.5512.616.35
Cash Growth
213.59%98.71%-
Receivables
8.0120.572.82
Other Current Assets
0.861.280.12
Total Current Assets
48.4234.469.29
Property, Plant & Equipment
30.9522.088.71
Total Long-Term Assets
30.9522.088.71
Total Assets
79.3756.5418
Accounts Payable
4.467.42.18
Deferred Revenue
0.10.10
Current Debt
1.331.661.95
Other Current Liabilities
18.791.90.49
Total Current Liabilities
24.6811.064.62
Long-Term Debt
5.426.475.69
Other Long-Term Liabilities
10.7200
Total Long-Term Liabilities
16.146.475.69
Total Liabilities
40.8217.5310.31
Total Debt
6.748.137.64
Debt Growth
-17.01%6.40%-
Common Stock
67.6850.9929.8
Retained Earnings
-29.13-11.98-32.1
Shareholders' Equity
38.5539.01-2.31
Total Liabilities and Equity
79.3756.548
Net Cash / Debt
32.84.48-1.29
Net Cash / Debt Growth
631.46%--
Net Cash Per Share
1.200.18-0.04
Working Capital
23.7423.394.67
Book Value Per Share
1.411.54-0.07
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).